Report cover image

Global Enalapril Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 193 Pages
SKU # APRC20356193

Description

Summary

According to APO Research, The global Enalapril market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Enalapril is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Enalapril is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Enalapril is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Enalapril is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Enalapril include Wockhardt Americas Inc, Watson Laboratories Inc, Teva Pharmaceuticals Usa Inc, Teva Parenteral Medicines Inc, Taro Pharmaceutical Industries Ltd, Sandoz Inc, Ranbaxy Laboratories Ltd, Mylan Pharmaceuticals Inc and Lek Pharmaceuticals D D, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Enalapril, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Enalapril, also provides the sales of main regions and countries. Of the upcoming market potential for Enalapril, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enalapril sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Enalapril market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Enalapril sales, projected growth trends, production technology, application and end-user industry.

Enalapril Segment by Company

Wockhardt Americas Inc
Watson Laboratories Inc
Teva Pharmaceuticals Usa Inc
Teva Parenteral Medicines Inc
Taro Pharmaceutical Industries Ltd
Sandoz Inc
Ranbaxy Laboratories Ltd
Mylan Pharmaceuticals Inc
Lek Pharmaceuticals D D
Krka Dd Novo Mesto
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
Hospira Inc
Hikma Farmaceutica (Portugal) Sa
Biovail Laboratories International Srl
Bedford Laboratories Div Ben Venue Laboratories Inc
Apothecon Inc Div Bristol Myers Squibb
Apotex Inc
Enalapril Segment by Type

10mg
2.5mg
20mg
5mg
Enalapril Segment by Application

Hospital
Drugs Store
Enalapril Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enalapril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enalapril and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enalapril.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enalapril market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enalapril manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enalapril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Enalapril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Enalapril Market Size, 2020 VS 2024 VS 2031
1.3 Global Enalapril Market Size Estimates and Forecasts (2020-2031)
1.4 Global Enalapril Sales Estimates and Forecasts (2020-2031)
1.5 Global Enalapril Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Enalapril Market Dynamics
2.1 Enalapril Industry Trends
2.2 Enalapril Industry Drivers
2.3 Enalapril Industry Opportunities and Challenges
2.4 Enalapril Industry Restraints
3 Enalapril Market by Manufacturers
3.1 Global Enalapril Revenue by Manufacturers (2020-2025)
3.2 Global Enalapril Sales by Manufacturers (2020-2025)
3.3 Global Enalapril Average Sales Price by Manufacturers (2020-2025)
3.4 Global Enalapril Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Enalapril Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Enalapril Manufacturers, Product Type & Application
3.7 Global Enalapril Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Enalapril Market CR5 and HHI
3.8.2 Global Top 5 and 10 Enalapril Players Market Share by Revenue in 2024
3.8.3 2024 Enalapril Tier 1, Tier 2, and Tier 3
4 Enalapril Market by Type
4.1 Enalapril Type Introduction
4.1.1 10mg
4.1.2 2.5mg
4.1.3 20mg
4.1.4 5mg
4.2 Global Enalapril Sales by Type
4.2.1 Global Enalapril Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Enalapril Sales by Type (2020-2031)
4.2.3 Global Enalapril Sales Market Share by Type (2020-2031)
4.3 Global Enalapril Revenue by Type
4.3.1 Global Enalapril Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Enalapril Revenue by Type (2020-2031)
4.3.3 Global Enalapril Revenue Market Share by Type (2020-2031)
5 Enalapril Market by Application
5.1 Enalapril Application Introduction
5.1.1 Hospital
5.1.2 Drugs Store
5.2 Global Enalapril Sales by Application
5.2.1 Global Enalapril Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Enalapril Sales by Application (2020-2031)
5.2.3 Global Enalapril Sales Market Share by Application (2020-2031)
5.3 Global Enalapril Revenue by Application
5.3.1 Global Enalapril Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Enalapril Revenue by Application (2020-2031)
5.3.3 Global Enalapril Revenue Market Share by Application (2020-2031)
6 Global Enalapril Sales by Region
6.1 Global Enalapril Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Enalapril Sales by Region (2020-2031)
6.2.1 Global Enalapril Sales by Region (2020-2025)
6.2.2 Global Enalapril Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Enalapril Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Enalapril Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Enalapril Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Enalapril Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Enalapril Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Enalapril Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Enalapril Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Enalapril Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Enalapril Revenue by Region
7.1 Global Enalapril Revenue by Region
7.1.1 Global Enalapril Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Enalapril Revenue by Region (2020-2025)
7.1.3 Global Enalapril Revenue by Region (2026-2031)
7.1.4 Global Enalapril Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Enalapril Revenue (2020-2031)
7.2.2 North America Enalapril Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Enalapril Revenue (2020-2031)
7.3.2 Europe Enalapril Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Enalapril Revenue (2020-2031)
7.4.2 Asia-Pacific Enalapril Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Enalapril Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Enalapril Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Wockhardt Americas Inc
8.1.1 Wockhardt Americas Inc Comapny Information
8.1.2 Wockhardt Americas Inc Business Overview
8.1.3 Wockhardt Americas Inc Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Wockhardt Americas Inc Enalapril Product Portfolio
8.1.5 Wockhardt Americas Inc Recent Developments
8.2 Watson Laboratories Inc
8.2.1 Watson Laboratories Inc Comapny Information
8.2.2 Watson Laboratories Inc Business Overview
8.2.3 Watson Laboratories Inc Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Watson Laboratories Inc Enalapril Product Portfolio
8.2.5 Watson Laboratories Inc Recent Developments
8.3 Teva Pharmaceuticals Usa Inc
8.3.1 Teva Pharmaceuticals Usa Inc Comapny Information
8.3.2 Teva Pharmaceuticals Usa Inc Business Overview
8.3.3 Teva Pharmaceuticals Usa Inc Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Teva Pharmaceuticals Usa Inc Enalapril Product Portfolio
8.3.5 Teva Pharmaceuticals Usa Inc Recent Developments
8.4 Teva Parenteral Medicines Inc
8.4.1 Teva Parenteral Medicines Inc Comapny Information
8.4.2 Teva Parenteral Medicines Inc Business Overview
8.4.3 Teva Parenteral Medicines Inc Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Teva Parenteral Medicines Inc Enalapril Product Portfolio
8.4.5 Teva Parenteral Medicines Inc Recent Developments
8.5 Taro Pharmaceutical Industries Ltd
8.5.1 Taro Pharmaceutical Industries Ltd Comapny Information
8.5.2 Taro Pharmaceutical Industries Ltd Business Overview
8.5.3 Taro Pharmaceutical Industries Ltd Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Taro Pharmaceutical Industries Ltd Enalapril Product Portfolio
8.5.5 Taro Pharmaceutical Industries Ltd Recent Developments
8.6 Sandoz Inc
8.6.1 Sandoz Inc Comapny Information
8.6.2 Sandoz Inc Business Overview
8.6.3 Sandoz Inc Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Sandoz Inc Enalapril Product Portfolio
8.6.5 Sandoz Inc Recent Developments
8.7 Ranbaxy Laboratories Ltd
8.7.1 Ranbaxy Laboratories Ltd Comapny Information
8.7.2 Ranbaxy Laboratories Ltd Business Overview
8.7.3 Ranbaxy Laboratories Ltd Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Ranbaxy Laboratories Ltd Enalapril Product Portfolio
8.7.5 Ranbaxy Laboratories Ltd Recent Developments
8.8 Mylan Pharmaceuticals Inc
8.8.1 Mylan Pharmaceuticals Inc Comapny Information
8.8.2 Mylan Pharmaceuticals Inc Business Overview
8.8.3 Mylan Pharmaceuticals Inc Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Mylan Pharmaceuticals Inc Enalapril Product Portfolio
8.8.5 Mylan Pharmaceuticals Inc Recent Developments
8.9 Lek Pharmaceuticals D D
8.9.1 Lek Pharmaceuticals D D Comapny Information
8.9.2 Lek Pharmaceuticals D D Business Overview
8.9.3 Lek Pharmaceuticals D D Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Lek Pharmaceuticals D D Enalapril Product Portfolio
8.9.5 Lek Pharmaceuticals D D Recent Developments
8.10 Krka Dd Novo Mesto
8.10.1 Krka Dd Novo Mesto Comapny Information
8.10.2 Krka Dd Novo Mesto Business Overview
8.10.3 Krka Dd Novo Mesto Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Krka Dd Novo Mesto Enalapril Product Portfolio
8.10.5 Krka Dd Novo Mesto Recent Developments
8.11 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
8.11.1 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Comapny Information
8.11.2 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Business Overview
8.11.3 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Product Portfolio
8.11.5 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Recent Developments
8.12 Hospira Inc
8.12.1 Hospira Inc Comapny Information
8.12.2 Hospira Inc Business Overview
8.12.3 Hospira Inc Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Hospira Inc Enalapril Product Portfolio
8.12.5 Hospira Inc Recent Developments
8.13 Hikma Farmaceutica (Portugal) Sa
8.13.1 Hikma Farmaceutica (Portugal) Sa Comapny Information
8.13.2 Hikma Farmaceutica (Portugal) Sa Business Overview
8.13.3 Hikma Farmaceutica (Portugal) Sa Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Hikma Farmaceutica (Portugal) Sa Enalapril Product Portfolio
8.13.5 Hikma Farmaceutica (Portugal) Sa Recent Developments
8.14 Biovail Laboratories International Srl
8.14.1 Biovail Laboratories International Srl Comapny Information
8.14.2 Biovail Laboratories International Srl Business Overview
8.14.3 Biovail Laboratories International Srl Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Biovail Laboratories International Srl Enalapril Product Portfolio
8.14.5 Biovail Laboratories International Srl Recent Developments
8.15 Bedford Laboratories Div Ben Venue Laboratories Inc
8.15.1 Bedford Laboratories Div Ben Venue Laboratories Inc Comapny Information
8.15.2 Bedford Laboratories Div Ben Venue Laboratories Inc Business Overview
8.15.3 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Product Portfolio
8.15.5 Bedford Laboratories Div Ben Venue Laboratories Inc Recent Developments
8.16 Apothecon Inc Div Bristol Myers Squibb
8.16.1 Apothecon Inc Div Bristol Myers Squibb Comapny Information
8.16.2 Apothecon Inc Div Bristol Myers Squibb Business Overview
8.16.3 Apothecon Inc Div Bristol Myers Squibb Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Apothecon Inc Div Bristol Myers Squibb Enalapril Product Portfolio
8.16.5 Apothecon Inc Div Bristol Myers Squibb Recent Developments
8.17 Apotex Inc
8.17.1 Apotex Inc Comapny Information
8.17.2 Apotex Inc Business Overview
8.17.3 Apotex Inc Enalapril Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 Apotex Inc Enalapril Product Portfolio
8.17.5 Apotex Inc Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Enalapril Value Chain Analysis
9.1.1 Enalapril Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Enalapril Production Mode & Process
9.2 Enalapril Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Enalapril Distributors
9.2.3 Enalapril Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.